OPNT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.15%

Insider Buying (Last 12 Months): $63,289.28

Insider Selling (Last 12 Months): $602,902.73

Opiant Pharmaceuticals Insider Trading History Chart

Opiant Pharmaceuticals Share Price & Price History

^$20.80

▲ +0.6 (2.97%)

As of 02/6/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Opiant Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/27/2023	Brian Gorman	General Counsel	Sell	444	$20.26	$8,995.44	31,990
1/27/2023	David D. O'Toole	CFO	Sell	541	$20.26	$10,960.66	34,248
1/27/2023	Mark Jason Heath Ellison	Insider	Sell	610	$20.26	$12,358.60	18,751
1/27/2023	Roger Crystal	CEO	Sell	1,358	$20.26	$27,513.08	75,339
1/9/2023	David D. O'Toole	CFO	Sell	415	$20.20	$8,383.00	34,789
1/9/2023	Mark Jason Heath Ellison	Insider	Sell	469	$20.20	$9,473.80	19,361
1/9/2023	Roger Crystal	CEO	Sell	1,183	$20.20	$23,896.60	76,697
1/5/2023	Brian Gorman	General Counsel	Sell	1,313	$20.20	$26,522.60	32,434
1/5/2023	David D. O'Toole	CFO	Sell	1,600	$20.20	$32,320.00	35,204
1/5/2023	Mark Jason Heath Ellison	Insider	Sell	1,806	$20.20	$36,481.20	19,830
1/5/2023	Roger Crystal	CEO	Sell	5,029	$20.20	$101,585.80	77,880
7/20/2022	Matthew R. Ruth	Insider	Sell	1,084	$10.62	$11,512.08	29,916
7/14/2022	Brian Gorman	General Counsel	Sell	691	$11.16	$7,711.56	33,747
7/14/2022	David D. O'Toole	CFO	Sell	779	$11.10	$8,646.90	36,804
7/14/2022	Phil Skolnick	Insider	Sell	627	$11.85	$7,429.95	23,818
7/14/2022	Roger Crystal	CEO	Sell	2,246	$11.11	$24,953.06	82,909
6/15/2022	Michael Sinclair	Director	Sell	900	$10.60	$9,540.00	19,220
6/13/2022	Craig A Collard	Director	Buy	4,037	$10.94	$44,164.78	53,822
6/10/2022	Craig A Collard	Director	Buy	1,663	$11.50	$19,124.50	49,785
6/6/2022	Michael Sinclair	Director	Sell	7,688	$12.94	$99,482.72	41,532
6/2/2022	Michael Sinclair	Director	Sell	9,736	$13.88	$135,135.68	59,484
1/27/2022	Phil Skolnick	Insider	Sell	1,518	$26.19	$39,756.42
1/27/2022	Roger Crystal	CEO	Sell	1,995	$26.15	$52,169.25
1/10/2022	David D. O'Toole	CFO	Sell	432	$30.60	$13,219.20
1/10/2022	Phil Skolnick	Insider	Sell	385	$30.49	$11,738.65
1/10/2022	Roger Crystal	CEO	Sell	1,058	$30.49	$32,258.42
9/21/2021	Thomas T. Thomas	Director	Sell	831	$24.12	$20,043.72
9/14/2021	David D. O'Toole	CFO	Buy	200	$19.12	$3,824.00
9/13/2021	Craig A. Collard	Director	Buy	2,500	$18.13	$45,325.00	16,077
8/31/2021	Matthew R. Ruth	Insider	Buy	2,000	$17.34	$34,680.00	17,000
8/25/2021	Michael Sinclair	Director	Sell	50,269	$14.69	$738,451.61
8/23/2021	Michael Sinclair	Director	Sell	65,124	$16.50	$1,074,546.00	209,194
8/16/2021	David D. O'Toole	CFO	Buy	600	$15.38	$9,228.00	23,815
3/17/2021	Gabrielle Alison Silver	Director	Sell	13,006	$11.31	$147,097.86
9/3/2020	Thomas T. Thomas	Director	Buy	2,500	$8.40	$21,000.00	4,500
6/11/2020	David D. O'Toole	CFO	Buy	1,000	$8.64	$8,640.00
5/26/2020	David D. O'Toole	CFO	Buy	1,000	$10.90	$10,900.00

"TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race

From Investing Trends | Ad

Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution.

Get the full story on this new opportunity

SEC Filings (Institutional Ownership Changes) for Opiant Pharmaceuticals (NASDAQ:OPNT)

42.39% of Opiant Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Opiant Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/25/2023	Lindbrook Capital LLC	2,000	$41K	0.0%	+300.0%	0.039%
11/15/2022	Two Sigma Advisers LP	23,400	$0.25M	0.0%	-68.5%	0.453%
11/15/2022	Two Sigma Investments LP	21,730	$0.23M	0.0%	-41.4%	0.421%
11/15/2022	Trexquant Investment LP	13,219	$0.14M	0.0%	+8.2%	0.256%
11/15/2022	Parkman Healthcare Partners LLC	76,530	$0.82M	0.2%	+1.2%	1.482%
11/15/2022	Essex Investment Management Co. LLC	47,169	$0.51M	0.1%	-6.4%	0.914%
11/14/2022	Renaissance Technologies LLC	176,915	$1.90M	0.0%	-8.5%	3.426%
11/10/2022	Dimensional Fund Advisors LP	112,492	$1.21M	0.0%	-11.6%	2.180%
10/26/2022	Mesirow Financial Investment Management Inc.	17,633	$0.19M	0.9%	N/A	0.342%
8/13/2022	Wells Fargo & Company MN	203,231	$2.44M	0.0%	-1.0%	4.001%
8/13/2022	Renaissance Technologies LLC	193,415	$2.32M	0.0%	+8.7%	3.807%
8/12/2022	Apis Capital Advisors LLC	196,000	$2.35M	2.6%	+75.0%	3.858%
8/12/2022	Essex Investment Management Co. LLC	50,405	$0.60M	0.1%	+57.3%	0.992%
7/8/2022	HealthInvest Partners AB	210,000	$2.52M	5.8%	+1,066.7%	4.134%
5/16/2022	State Street Corp	13,285	$0.29M	0.0%	+10.7%	0.262%
5/13/2022	Renaissance Technologies LLC	178,015	$3.81M	0.0%	-3.2%	3.504%
5/13/2022	Mariner LLC	13,550	$0.29M	0.0%	N/A	0.267%
5/13/2022	Parkman Healthcare Partners LLC	32,557	$0.70M	0.2%	+4.0%	0.641%
5/13/2022	Apis Capital Advisors LLC	112,000	$2.40M	2.9%	+1.8%	2.205%
5/13/2022	DLD Asset Management LP	20,000	$0.43M	0.0%	-33.3%	0.394%
5/13/2022	Vanguard Group Inc.	187,158	$4.01M	0.0%	+4.9%	3.684%
5/13/2022	Dimensional Fund Advisors LP	106,682	$2.29M	0.0%	+60.1%	2.100%
5/12/2022	Acadian Asset Management LLC	116,478	$2.49M	0.0%	+62.0%	2.293%
5/11/2022	Ovata Capital Management Ltd	117,865	$2.53M	0.8%	N/A	2.320%
5/11/2022	JPMorgan Chase & Co.	7,466	$0.16M	0.0%	+10.7%	0.147%
5/9/2022	Essex Investment Management Co. LLC	32,040	$0.69M	0.1%	+2.5%	0.631%
5/5/2022	HealthInvest Partners AB	18,000	$0.39M	0.6%	N/A	0.354%
5/4/2022	Advisor Group Holdings Inc.	5,425	$0.12M	0.0%	-33.2%	0.107%
4/25/2022	Bailard Inc.	15,042	$0.32M	0.0%	-7.4%	0.296%
2/22/2022	DLD Asset Management LP	30,000	$1.01M	0.0%	N/A	0.636%
2/15/2022	DLD Asset Management LP	30,000	$1.01M	0.1%	N/A	0.636%
2/11/2022	Renaissance Technologies LLC	183,815	$6.18M	0.0%	-10.6%	3.894%
2/10/2022	Essex Investment Management Co. LLC	31,263	$1.05M	0.1%	+26.1%	0.662%
2/10/2022	Acadian Asset Management LLC	71,916	$2.42M	0.0%	+11.6%	1.524%
2/9/2022	Dimensional Fund Advisors LP	66,651	$2.24M	0.0%	+51.1%	1.412%
2/7/2022	Hillsdale Investment Management Inc.	3,200	$0.11M	0.0%	N/A	0.068%
2/3/2022	Advisor Group Holdings Inc.	8,125	$0.27M	0.0%	+28.5%	0.172%
1/27/2022	Dorsey Wright & Associates	2,138	$72K	0.0%	N/A	0.045%
1/19/2022	Marquette Asset Management LLC	5,180	$0.17M	0.0%	-34.8%	0.110%
11/16/2021	Two Sigma Advisers LP	83,100	$2.14M	0.0%	N/A	1.889%
11/16/2021	Two Sigma Investments LP	51,045	$1.31M	0.0%	N/A	1.160%
11/12/2021	Renaissance Technologies LLC	205,615	$5.29M	0.0%	+7.5%	4.673%
11/12/2021	Apis Capital Advisors LLC	102,000	$2.63M	2.5%	+21.4%	2.318%
11/12/2021	Parkman Healthcare Partners LLC	30,000	$0.77M	0.2%	N/A	0.682%
11/12/2021	Geode Capital Management LLC	50,244	$1.29M	0.0%	+290.0%	1.142%
11/12/2021	EAM Investors LLC	69,046	$1.78M	0.3%	N/A	1.569%
11/9/2021	Essex Investment Management Co. LLC	24,792	$0.64M	0.1%	N/A	0.563%
11/9/2021	BlackRock Inc.	24,686	$0.64M	0.0%	+107.2%	0.561%
11/5/2021	Advisor Group Holdings Inc.	6,325	$0.16M	0.0%	+102.4%	0.144%
9/7/2021	Newbridge Financial Services Group Inc.	2,500	$33K	0.0%	-52.8%	0.057%
8/17/2021	Wells Fargo & Company MN	251,007	$3.36M	0.0%	+0.4%	5.705%
8/17/2021	Apis Capital Advisors LLC	84,000	$1.12M	1.0%	+5.0%	1.909%
8/13/2021	Renaissance Technologies LLC	191,315	$2.56M	0.0%	-14.1%	4.348%
8/13/2021	Northern Trust Corp	37,958	$0.51M	0.0%	+17.6%	0.863%
8/13/2021	Vanguard Group Inc.	136,965	$1.83M	0.0%	+21.2%	3.113%
5/21/2021	Citadel Advisors LLC	11,110	$0.12M	0.0%	-12.1%	0.257%
5/18/2021	Citadel Advisors LLC	11,110	$0.12M	0.0%	-12.1%	0.257%
5/14/2021	Dimensional Fund Advisors LP	21,831	$0.23M	0.0%	+11.5%	0.504%
5/13/2021	Renaissance Technologies LLC	222,815	$2.37M	0.0%	-5.9%	5.145%
5/12/2021	Northern Trust Corp	32,290	$0.34M	0.0%	-37.5%	0.746%
5/12/2021	Geode Capital Management LLC	12,882	$0.14M	0.0%	N/A	0.297%
5/11/2021	Acadian Asset Management LLC	59,831	$0.64M	0.0%	-1.7%	1.381%
2/16/2021	Apis Capital Advisors LLC	64,000	$0.51M	0.5%	N/A	1.503%
2/11/2021	Northern Trust Corp	51,634	$0.42M	0.0%	-13.6%	1.213%
2/10/2021	Renaissance Technologies LLC	236,815	$1.90M	0.0%	+9.7%	5.562%
2/9/2021	Wells Fargo & Company MN	252,205	$2.03M	0.0%	+21.9%	5.923%
11/16/2020	Squarepoint Ops LLC	12,087	$90K	0.0%	N/A	0.284%
11/13/2020	Morgan Stanley	10,714	$80K	0.0%	+39.1%	0.252%
11/9/2020	Acadian Asset Management LLC	62,048	$0.46M	0.0%	+90.8%	1.457%
11/6/2020	BlackRock Inc.	29,491	$0.22M	0.0%	+43.6%	0.693%
11/6/2020	GSA Capital Partners LLP	27,110	$0.20M	0.0%	+100.4%	0.637%
11/5/2020	Wells Fargo & Company MN	206,950	$1.55M	0.0%	+85.5%	4.860%
10/27/2020	Marquette Asset Management LLC	7,941	$59K	0.0%	N/A	0.186%
8/14/2020	Advisor Group Holdings Inc.	3,575	$32K	0.0%	-25.1%	0.084%
8/13/2020	Perritt Capital Management Inc.	29,500	$0.27M	0.2%	-21.3%	0.693%
5/18/2020	Advisor Group Holdings Inc.	4,775	$45K	0.0%	N/A	0.112%
5/15/2020	Fondren Management LP	314,300	$3.01M	7.6%	+18.6%	7.381%
5/15/2020	Morgan Stanley	4,542	$44K	0.0%	+27.8%	0.107%
5/14/2020	Stonepine Capital Management LLC	380,948	$3.65M	3.9%	+14.0%	8.947%
5/11/2020	Acadian Asset Management LLC	8,128	$79K	0.0%	+439.7%	0.191%
5/11/2020	Alambic Investment Management L.P.	15,312	$0.15M	0.4%	N/A	0.359%
5/1/2020	BlackRock Inc.	20,727	$0.20M	0.0%	-22.4%	0.489%
4/13/2020	Wedge Capital Management L L P NC	12,914	$0.12M	0.0%	-43.1%	0.305%
4/9/2020	Mesirow Financial Investment Management Inc.	20,216	$0.19M	1.2%	N/A	0.477%
2/13/2020	Renaissance Technologies LLC	41,028	$0.59M	0.0%	+169.8%	1.002%
2/12/2020	Advisor Group Inc.	6,600	$96K	0.0%	+43.5%	0.161%
2/5/2020	Perritt Capital Management Inc.	36,000	$0.52M	0.2%	+7.5%	0.879%
2/4/2020	Tobias Financial Advisors Inc.	2,724	$39K	0.0%	N/A	0.067%
2/4/2020	Advisory Services Network LLC	6,000	$86K	0.0%	N/A	0.147%
1/27/2020	TCI Wealth Advisors Inc.	3,475	$50K	0.0%	N/A	0.085%
1/15/2020	Wedge Capital Management L L P NC	22,697	$0.33M	0.0%	-6.0%	0.554%
11/1/2019	Wedge Capital Management L L P NC	24,151	$0.36M	0.0%	N/A	0.598%
8/14/2019	Morgan Stanley	22,414	$0.30M	0.0%	+1,000.3%	0.555%
8/13/2019	Stonepine Capital Management LLC	315,468	$4.18M	2.9%	+7.0%	8.037%
8/13/2019	BlackRock Inc.	20,792	$0.28M	0.0%	+93.5%	0.530%
8/7/2019	Granite Investment Partners LLC	14,453	$0.19M	0.0%	-46.8%	0.368%
7/31/2019	Advisor Group Inc.	4,600	$61K	0.0%	+24.3%	0.117%
5/13/2019	Granite Investment Partners LLC	27,143	$0.36M	0.0%	N/A	0.692%
5/7/2019	Spark Investment Management LLC	15,100	$0.20M	0.0%	+17.6%	0.385%
2/19/2019	UBS Oconnor LLC	24,373	$0.35M	0.0%	-18.5%	0.636%

Data available starting January 2016

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.

Today's Range

Now: $20.80

$20.40

$21.13

50 Day Range

MA: $20.26

$20.03

$20.80

52 Week Range

Now: $20.80

$7.34

$32.27

Volume

237,709 shs

Average Volume

82,100 shs

Market Capitalization

$107.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Opiant Pharmaceuticals?: Opiant Pharmaceuticals' top insider shareholders include:
Michael Sinclair (Director)
Roger Crystal (CEO)
Craig A Collard (Director)
David D O'toole (CFO)
Brian Gorman (General Counsel)
Matthew R Ruth (Insider)
Phil Skolnick (Insider)
Mark Jason Heath Ellison (Insider)
Craig A Collard (Director)
Gabrielle Alison Silver (Director)
Thomas T Thomas (Director)
Learn More about top insider investors at Opiant Pharmaceuticals.
Who are the major institutional investors of Opiant Pharmaceuticals?: Opiant Pharmaceuticals' top institutional shareholders include:
Lindbrook Capital LLC — 0.04%
Learn More about top institutional investors of Opiant Pharmaceuticals stock.
Which major investors are buying Opiant Pharmaceuticals stock?: In the previous quarter, OPNT stock was bought by institutional investors including:
Lindbrook Capital LLC
In the last year, these company insiders have bought Opiant Pharmaceuticals stock:
Michael Sinclair (Director)
Roger Crystal (CEO)
Craig A Collard (Director)
David D O'toole (CFO)
Learn More investors buying Opiant Pharmaceuticals stock.